Deficits in auditory P50 inhibition in obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 288-296

  Hashimoto, Tasuku ^a   Shimizu, Eiji ^a   Koike, Kaori ^a   Orita, Yasuhiro ^a   Suzuki, Tomotaka ^a   Kanahara, Nobuhisa ^a   Matsuzawa, Daisuke ^a   Fukami, Goro ^a   Miyatake, Ryosuke ^a   Shinoda, Naoyuki ^a   Fujisaki, Mihisa ^a   Shirayama, Yukihiko ^a   Hashimoto, Kenji ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Auditory evoked potential; Neuropsychological tests; Obsessive compulsive disorder; P50 inhibition; Sensory gating

Indexed keywords

ADULT; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); MALE; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; SYMBOL DIGIT MODALITIES TEST;

ACOUSTIC STIMULATION; ADULT; CASE-CONTROL STUDIES; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC;

EID: 38349025884     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.021     Document Type: Article

References (75)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., and Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17 (1982) 639-654
2. Adler L.E., Gerhardt G.A., Franks R., Baker N., Nagamoto H., Drebing C., et al. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res 31 (1990) 297-309
3. Adler L.E., Hoffer L.D., Wiser A., and Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150 (1993) 1856-1861
4. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24 (1998) 189-202
5. Adler L.E., Olincy A., Cawthra E.M., McRae K.A., Harris J.G., Nagamoto H.T., et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 161 (2004) 1822-1828
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Association Press, Washington, DC
7. Arciniegas D.B., Topkoff J.L., Rojas D.C., Sheeder J., Teale P., Young D.A., et al. Reduced hippocampal volume in association with p50 nonsuppression following traumatic brain injury. J Neuropsychiatry Clin Neurosci 13 (2001) 213-221
8. Bannon S., Gonsalvez C.J., Croft R.J., and Boyce P.M. Response inhibition deficits in obsessive-compulsive disorder. Psychiatry Res 110 (2002) 165-174
9. Bartz J.A., and Hollander E. Is obsessive-compulsive disorder an anxiety disorder?. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 338-352
10. Beck A., Ward C., Mendelson M., Mock J., and Frbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-591
11. Bejerot S., and Humble M. Low prevalence of smoking among patients with obsessive-compulsive disorder. Compr Psychiatry 40 (1999) 268-272
12. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47 (1990) 181-188
13. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156 (2001) 234-258
14. Braff D.L., Light G.A., and Swerdlow N.R. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 61 (2007) 1204-1207
15. Brenner C.A., Edwards C.R., Carroll C.A., Kieffaber P.D., and Hetrick W.P. P50 and acoustic startle gating are not related in healthy participants. Psychophysiology 41 (2004) 702-708
16. Cadenhead K.S., Light G.A., Geyer M.A., and Braff D.L. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157 (2000) 55-59
17. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., and Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39 (1996) 33-41
18. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., and Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29 (2005) 399-419
19. Choi J.S., Kim H.S., Yoo S.Y., Ha T.H., Chang J.H., Kim Y.Y., et al. Morphometric alterations of anterior superior temporal cortex in obsessive-compulsive disorder. Depress Anxiety 23 (2006) 290-296
20. Clementz B.A., Geyer M.A., and Braff D.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 155 (1998) 1691-1694
21. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T., et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res 10 (1993) 131-141
22. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., and Gur R.E. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr Res 33 (1998) 157-167
23. Fann A.V., Preston M.A., Bray P., Mamiya N., Williams D.K., Skinner R.D., et al. The P50 midlatency auditory evoked potential in patients with chronic low back pain (CLBP). Clin Neurophysiol 116 (2005) 681-689
24. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94 (1997) 587-592
25. Ghisolfi E.S., Heldt E., Zanardo A.P., Strimitzer Jr. I.M., Prokopiuk A.S., Becker J., et al. P50 sensory gating in panic disorder. J Psychiatr Res 40 (2006) 535-540
26. Ghisolfi E.S., Schuch A., Strimitzer Jr. I.M., Luersen G., Martins F.F., Ramos F.L., et al. Caffeine modulates P50 auditory sensory gating in healthy subjects. Eur Neuropsychopharmacol 16 (2006) 204-210
27. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 46 (1989) 1006-1016
28. Greenberg B.D., Ziemann U., Cora-Locatelli G., Harmon A., Murphy D.L., Keel J.C., et al. Altered cortical excitability in obsessive-compulsive disorder. Neurology 54 (2000) 142-147
29. Hall M.H., Schulze K., Rijsdijk F., Picchioni M., Ettinger U., Bramon E., et al. Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet 36 (2006) 845-857
30. Hammer T.B., Oranje B., and Glenthoj B.Y. The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol (2007) 1-9
31. Harris J.G., Kongs S., Allensworth D., Martin L., Tregellas J., Sullivan B., et al. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29 (2004) 1378-1385
32. Herrmann M.J., Jacob C., Unterecker S., and Fallgatter A.J. Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping. Psychiatry Res 120 (2003) 265-271
33. Heyman I., Mataix-Cols D., and Fineberg N.A. Obsessive-compulsive disorder. BMJ 333 7565 (2006) 424-429
34. Hoenig K., Hochrein A., Quednow B.B., Maier W., and Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 57 (2005) 1153-1158
35. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., and Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55 (2004) 850-858
36. Kim M.S., Kang S.S., Youn T., Kang D.H., Kim J.J., and Kwon J.S. Neuropsychological correlates of P300 abnormalities in patients with schizophrenia and obsessive-compulsive disorder. Psychiatry Res 123 (2003) 109-123
37. Koike K., Hashimoto K., Takai N., Shimizu E., Komatsu N., Watanabe H., et al. Tropisetron improves deficits in auditory P50 suppression in schizophrenia. Schizophr Res 76 (2005) 67-72
38. Kuelz A.K., Hohagen F., and Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol 65 (2004) 185-236
39. Kwon J.S., Shin Y.W., Kim C.W., Kim Y.I., Youn T., Han M.H., et al. Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 74 (2003) 962-964
40. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., et al. Smoking and mental illness. Pharmacol Biochem Behav 70 (2001) 561-570
41. Liechti M.E., Geyer M.A., Hell D., and Vollenweider F.X. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 24 (2001) 240-252
42. Maihofner C., Sperling W., Kaltenhauser M., Bleich S., de Zwaan M., Wiltfang J., et al. Spontaneous magnetoencephalographic activity in patients with obsessive-compulsive disorder. Brain Res 1129 (2007) 200-205
43. Moritz S., Birkner C., Kloss M., Jahn H., Hand I., Haasen C., et al. Executive functioning in Obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol 17 (2002) 477-483
44. Muller J., and Roberts J.E. Memory and attention in obsessive-compulsive disorder: a review. J Anxiety Disord 19 (2005) 1-28
45. Myers C.S., Robles O., Kakoyannis A.N., Sherr J.D., Avila M.T., Blaxton T.A., et al. Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl) 174 (2004) 334-340
46. Nagamoto H.T., Adler L.E., Waldo M.C., and Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 25 (1989) 549-561
47. Neylan T.C., Fletcher D.J., Lenoci M., McCallin K., Weiss D.S., Schoenfeld F.B., et al. Sensory gating in chronic posttraumatic stress disorder: reduced auditory P50 suppression in combat veterans. Biol Psychiatry 46 (1999) 1656-1664
48. Oranje B., Gispen-de Wied C.C., Westenberg H.G., Kemner C., Verbaten M.N., and Kahn R.S. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. J Psychopharmacol 18 (2004) 388-394
49. Penadés R., Catalán R., Andrés S., Salamero M., and Gastó C. Executive function and nonverbal memory in obsessive-compulsive disorder. Psychiatry Res 133 (2005) 81-90
50. Phillips M.A., Langley R.W., Bradshaw C.M., and Szabadi E. The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 14 (2000) 40-45
51. Potter D., Summerfelt A., Gold J., and Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull 32 (2006) 692-700
52. Purcell R., Maruff P., Kyrios M., and Pantelis C. Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function. Biol Psychiatry 43 (1998) 348-357
53. Purcell R., Maruff P., Kyrios M., and Pantelis C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 55 (1998) 415-423
54. Rauch S.L., Wedig M.M., Wright C.I., Martis B., McMullin K.G., Shin L.M., et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 61 (2007) 330-336
55. Raux G., Bonnet-Brilhault F., and Louchart S. The -2 bp deletion in exon 6 of the 'dalpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Mol Psychiatry 7 (2002) 1006-1111
56. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery (1985), Neuropsychology Press, Tucson
57. Rosenberg D.R., Averbach D.H., O'Hearn K.M., Seymour A.B., Birmaher B., and Sweeney J.A. Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder. Arch Gen Psychiatry 54 (1997) 831-838
58. Rossi S., Bartalini S., Ulivelli M., Mantovani A., Di Muro A., Goracci A., et al. Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. Biol Psychiatry 57 (2005) 16-20
59. Savage C.R., Baer L., Keuthen N.J., Brown H.D., Rauch S.L., and Jenike M.A. Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry 45 (1999) 905-916
60. Schall U., Schön A., Zerbin D., Eggers C., and Oades R.D. Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. Int J Neurosci 84 (1996) 15-33
61. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
62. Simpson H.B., Rosen W., Huppert J.D., Lin S.H., Foa E.B., and Liebowitz M.R. Are there reliable neuropsychological deficits in Obsessive-compulsive disorder?. J Psychiatr Res 40 (2006) 247-257
63. Smith A. Symbol Digit Modalities Test-revised, manual (1982), Western Psychological Services, Los Angeles
64. Smith R.C., Singh A., Infante M., Khandat A., and Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27 (2002) 479-497
65. Spengler D., Trillenberg P., Sprenger A., Nagel M., Kordon A., Junghanns K., et al. Evidence from increased anticipation of predictive saccades for a dysfunction of fronto-striatal circuits in obsessive-compulsive disorder. Psychiatry Res 143 (2006) 77-88
66. Stein D.J. Obsessive-compulsive disorder. Lancet 360 (2002) 397-405
67. Sugishita M. Japanese version of Wechsler Memory Scale-revised, manual (2001), Nihon Bunka Kagakusha Corp, Tokyo
68. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., and Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry 50 (2001) 578-585
69. Thoma R.J., Hanlon F.M., Moses S.N., Ricker D., Huang M., Edgar C., et al. M50 sensory gating predicts negative symptoms in schizophrenia. Schizophr Res 73 (2005) 311-318
70. Towey J., Bruder G., Tenke C., Leite P., DeCaria C., Friedman D., et al. Event-related potential and clinical correlates of neurodysfunction in obsessive-compulsive disorder. Psychiatry Res 49 (1993) 167-181
71. Tregellas J.R., Davalos D.B., Rojas D.C., Waldo M.C., Gibson L., Wylie K., et al. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 92 (2007) 262-272
72. Tien A.Y., Pearlson G.D., Machlin S.R., Bylsma F.W., and Hoehn-Saric R. Oculomotor performance in obsessive-compulsive disorder. Am J Psychiatry 149 (1992) 641-646
73. van den Heuvel O.A., Veltman D.J., Groenewegen H.J., Witter M.P., Merkelbach J., Cath D.C., et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry 62 (2005) 922-933
74. van der Wee N.J., Hardeman H.H., Ramsey N.F., Raemaekers M., Van Megen H.J., Denys D.A., et al. Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidity. Psychol Med 36 (2006) 1321-1326
75. Wechsler D. Wechsler Memory Scale-revised, manual (1987), Psychological Corp, New York